Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? Journal:Hepatology Communications | 15-May-2023 | |||
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysis Journal:Asian Pacific Journal of Cancer Prevention | 2013 | 90 |